PPARA and obesity due to melanocortin 4 receptor deficiency: Significantly alleviates obesity and low-grade inflammation. Reduces hepatic steatosis and upregulates hepatic peroxisome proliferator-activated receptor alpha (PPARα) mRNA and protein expression.